Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor
- PMID: 14973326
- DOI: 10.1152/jn.00745.2003
Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor
Abstract
The search for an endogenous ligand for the vanilloid receptor (VR or TRPV1) has led to the identification of N-arachidonyl dopamine (NADA). This study investigates the role of protein kinase C (PKC)-mediated phosphorylation on NADA-induced membrane currents in Xenopus oocytes heterologously expressing TRPV1 and in dorsal root ganglion (DRG) neurons. In basal state, current induced by 10 microM NADA is 5-10% of the current induced by 1 microM capsaicin or protons at pH 5. However, PKC activator, phorbol 12,13-dibutyrate (PDBu) strongly potentiated ( approximately 15-fold) the NADA-induced current. Repeated application of NADA at short intervals potentiated its own response approximately fivefold in a PKC-dependent manner. PKC inhibitor, bisindolylmaleimide (BIM, 500 nM), a mutant TRPV1 (S800A/S502A), and maximal activation of PKC abolished the potentiation induced by repeated application of NADA. As a further confirmation that NADA could stimulate PKC, pretreatment with NADA potentiated the response of protons at pH 5 (approximately 20 fold), which was dramatically reduced in the mutant TRPV1. In DRG neurons, capsaicin (100 nM) induced a approximately 15 mV depolarization and initiated a train of action potentials compared with 1 microM NADA that produced a approximately 5 mV response. Pretreatment with PDBu induced significantly larger depolarization and potentiated NADA-induced current. Furthermore, exposure of NADA to the intracellular surface of the membrane-induced larger currents suggesting inaccessibility to the intracellular binding site might contribute to its weaker action. These results indicate that NADA is a potent agonist of VR when the receptor is in the PKC-mediated phosphorylation state.
Similar articles
-
Proton conductance of human transient receptor potential-vanilloid type-1 expressed in oocytes of Xenopus laevis and in Chinese hamster ovary cells.Neuroscience. 2004;125(4):861-6. doi: 10.1016/j.neuroscience.2004.02.032. Neuroscience. 2004. PMID: 15120847
-
TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat.Eur J Neurosci. 2004 Jul;20(1):175-84. doi: 10.1111/j.1460-9568.2004.03481.x. Eur J Neurosci. 2004. PMID: 15245490
-
Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.Eur J Pharmacol. 2008 Oct 31;596(1-3):62-9. doi: 10.1016/j.ejphar.2008.07.063. Epub 2008 Aug 5. Eur J Pharmacol. 2008. PMID: 18755179
-
Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse.J Physiol. 2007 Jun 1;581(Pt 2):631-47. doi: 10.1113/jphysiol.2006.118620. Epub 2007 Mar 15. J Physiol. 2007. PMID: 17363391 Free PMC article.
-
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities.Cannabis Cannabinoid Res. 2017 Jul 1;2(1):183-196. doi: 10.1089/can.2017.0015. eCollection 2017. Cannabis Cannabinoid Res. 2017. PMID: 29082315 Free PMC article. Review.
Cited by
-
TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation.J Neurosci. 2004 Oct 27;24(43):9521-30. doi: 10.1523/JNEUROSCI.2639-04.2004. J Neurosci. 2004. PMID: 15509739 Free PMC article.
-
Activation of astrocytic PAR1 receptors in the rat nucleus of the solitary tract regulates breathing through modulation of presynaptic TRPV1.J Physiol. 2018 Feb 1;596(3):497-513. doi: 10.1113/JP275127. Epub 2018 Jan 15. J Physiol. 2018. PMID: 29235097 Free PMC article.
-
Calcium-dependent and independent mechanisms of capsaicin receptor (TRPV1)-mediated cytokine production and cell death in human bronchial epithelial cells.J Biochem Mol Toxicol. 2005;19(4):266-75. doi: 10.1002/jbt.20084. J Biochem Mol Toxicol. 2005. PMID: 16173059 Free PMC article.
-
The expanding field of cannabimimetic and related lipid mediators.Br J Pharmacol. 2005 Feb;144(4):459-65. doi: 10.1038/sj.bjp.0706093. Br J Pharmacol. 2005. PMID: 15655504 Free PMC article. Review.
-
TRPV1 is a novel target for omega-3 polyunsaturated fatty acids.J Physiol. 2007 Jan 15;578(Pt 2):397-411. doi: 10.1113/jphysiol.2006.121988. Epub 2006 Oct 12. J Physiol. 2007. PMID: 17038422 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials